Yahoo Web Search

  1. Yahoo Finance Results

  2. Pfizer Inc. Stock Has a Great Storyline That’s Not Panning Out

    InvestorPlace via Yahoo FinanceApr 17 4:38 AM

    At first glance, Pfizer Inc. (NYSE:PFE) appears a worthwhile contrarian trade. Additionally, the overall markets have been soft, allowing shrewd investors to pick up PFE stock ...

  3. Pfizer Inc. PFE has announced initiation of dosing in a phase Ib study, evaluating its mini-dystrophin gene therapy candidate, PF-06939926, for the treatment of boys aged from ...

    36.85+0.17 (+0.46%)

    at Thu, Apr 26, 2018, 15:01PM EST - U.S. Markets open in 8 hrs 46 mins

    After Hours 36.95 +0.10 (+0.27%)

    Delayed Quote

    • Open 36.80
    • High 37.10
    • Low 36.75
    • 52 Wk. High 39.43
    • 52 Wk. Low 31.67
    • Mkt. Cap 219.21B
  4. Is Cellectis SA Stock a Buy Now?

    Motley Fool via Yahoo FinanceApr 07 12:36 PM

    In fact, shares of the French biotech spiked, albeit briefly, after Pfizer announced a handoff to newly formed Allogene Therapeutics, a biotech start-up headed by a couple of guys who ...

  5. Pfizer's Kidney Cancer Drug Misses Endpoint in Phase III

    Zacks via Yahoo FinanceApr 11 15:12 PM

    Shares of Pfizer have risen 0.2% so far this year, comparing favorably with a 2.3% decrease for the industry.

  6. 5 Healthcare Stocks To Buy Today

    InvestorPlace via Yahoo FinanceApr 06 20:18 PM

    From medical device firms to small biotech stocks, the healthcare sector has been hit hard over the last few weeks. With that, the recent patch of lower returns could be seen as huge buying ...

  7. The gene therapy space has once again hogged the limelight following the Swiss pharma giant Novartis’ NVS announcement of the acquisition of AveXis, Inc. AVXS. Per the agreement, Novartis ...

  8. 10 Safe Dividend Stocks for the Second Quarter

    InvestorPlace via Yahoo FinanceApr 06 20:18 PM

    While this deal will increase AT&T’s debt burden, Simply Safe Dividends estimates that the combined company’s free cash flow payout ratio will sit around 70% to 80%, which is sustainable for ...

  9. vTv Therapeutics Crashes on Alzheimer's Drug Study Failure

    Zacks via Yahoo FinanceApr 10 14:56 PM

    Shares of vTv Therapeutics, Inc. VTVT plummeted significantly after the company announced dismal results from the part A of the phase III trial, STEADFAST, on pipeline candidate, azeliragon ...

  10. Top ETF Picks for Your IRA

    Zacks via Yahoo FinanceApr 12 18:34 PM

    ETFs are excellent tools for retirement investors as well since they provide an easy way to build a diversified portfolio at a low cost. Further, income paying ETFs are better placed in an IRA ...

  11. Biogen Cracks the Case With AbbVie for Humira Biosimilar

    Zacks via Yahoo FinanceApr 09 5:12 AM

    Also in the United States, Samsung Bioepis entered into a settlement agreement with AbbVie, which would allow the former to bring Humira biosimilar into the U.S. market by Jan 31, 2023. Imraldi ...

  1. Ads
    related to Pfizer Inc